Skip to content
FIND A HEALTH VALLEY ACTOR

Moderna plans to produce a RNA vaccine against RSV in Valais

Moderna

Moderna, which developed one of the first messenger RNA vaccines against Covid-19, has disclosed positive preliminary results for a trial against the Respiratory Syncytial Virus (RSV), which causes bronchiolitis, in the elderly. The vaccine will be produced in Boston (USA) and in Visp (Switzerland)   The phase 3 trial is being conducted in a double-blind…

Read More